Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-08 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 7e-07 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-07 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |